California Avandia Lawyers
As consumers, we rely on the pharmaceutical companies to manufacture and make available to us, the safest and most effective drugs we need to treat our illnesses. Unfortunately, these companies get blindsided by their profit and forget their main objective. With only profit in mind, pharmaceutical companies are too quick to get their products on the market. This results in inadequate testing and unforeseen side effects.
Recently a study was conducted on Avandia, a prescription medication produced by GlaxoSmithKline, for treating Type 2 Diabetes. The drug generates about $3.2 billion a year for GlaxoSmithKline. The drug was introduced to the market in 1999.
The findings of the recent study were to be published in The New England Journal of Medicine in the upcoming weeks. The findings were so shocking, that The New England Journal of Medicine took it upon themselves to warn the public before the publishing date of the publication. The study concluded that by taking Avandia, a patient was increasing their risk of a heart attack by 43%, even worse; it increases their risk of death from cardiovascular disease by 64%.
With numbers so high, it is no wonder these findings were released early. It is also very unfortunate that these findings are only being discovered now, 8 years after the release of the drug. More unfortunate, these findings were not those of the pharmaceutical company, but of a medical organization. These tests should have been run before the drug was ever available to the public.
When confronted on the recent findings, the CEO of GlaxoSmithKline stated that the public's concern about Avandia is an "overreaction".